Skip to main content
SpringerLink
Log in

AEs and interactions limit options in treatment-resistant depression

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zhdanava M, et al. Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression Advances in Therapy : 9 Aug 2021. Available from: URL: https://doi.org/10.1007/s12325-021-01862-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AEs and interactions limit options in treatment-resistant depression. Reactions Weekly 1869, 6 (2021). https://doi.org/10.1007/s40278-021-00871-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-00871-z

Search

Navigation